Introducing Mosaic –
our FDA-cleared software platform for the analysis
of arterial disease using computed tomography
angiography (CTA) scans.

Cutting edge AI models being developed into Mosaic
enable new ways to detect high-risk and early-stage
disease, create pathways for interventional and
surgical planning, and allow for more personalised
treatment of patients suffering from disease.